跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Quince Extract
首页
药物
Quince Extract
Quince Extract
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical Composition
US 2013259952 A1
申请人: MARUZEN PHARM CO LTD
优先权: 2010
CN
US
3 件公开
Traditional Chinese herbal medicine pilatory
CN 1504226 A
申请人: FANG TAO
优先权: 2002
CN
Crude drug composition for cartilage regeneration, pain suppression, and edema suppression
CN 102076348 A
申请人: HELIXIR CO LTD
优先权: 2009
CN
Chinese medicament for treating femoral head necrosis and preparation method thereof
CN 101862430 B
申请人: JINMIN ZHANG
优先权: 2010
CN
Chinese medicinal preparation for treating protrasion of the lumbar intervertebral disci
CN 101884705 A
申请人: SHUMAO JIANG
优先权: 2010
CN
Anti-influenza virus agent
CN 102573866 A
申请人: LOTTE CO LTD
优先权: 2010
CN
Chinese medicament for treating sciatica and preparation method and application thereof
CN 101961400 B
申请人: KUNMING INST BOTANY CN ACAD
优先权: 2010
CN
Medicament for treating diabetes mellitus
CN 102100828 A
申请人: QILING WANG
优先权: 2011
CN
Pandemic influenza antiviral agent
CN 103501798 A
申请人: LOTTE CO LTD
优先权: 2012
CN
Deer sinew gout healthcare wine
CN 104398608 A
申请人: GAO DELONG
优先权: 2014
CN
第 1 / 3 页
上一页
下一页
药物
反馈